- Report
- November 2023
- 131 Pages
Global
From €5248EUR$5,500USD£4,396GBP
- Report
- October 2024
- 195 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- February 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- January 2024
- 200 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- January 2024
- 200 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- October 2024
- 162 Pages
Global
From €5200EUR$5,450USD£4,356GBP
- Report
- May 2024
- 135 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €2862EUR$3,000USD£2,398GBP
- Report
- May 2024
- 185 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- April 2024
- 100 Pages
Africa
From €1908EUR$2,000USD£1,598GBP
- Report
- April 2024
- 80 Pages
United States
From €1431EUR$1,500USD£1,199GBP
- Report
- May 2024
- 132 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Report
- May 2024
- 130 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Report
- May 2024
- 131 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Report
- May 2024
- 138 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Drug Pipelines
- July 2024
- 80 Pages
Global
From €1908EUR$2,000USD£1,598GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
- Report
- June 2024
- 200 Pages
Global
From €7585EUR$7,950USD£6,354GBP
The Melanoma Drug market is a subset of the larger Skin Cancer Drugs market. It is composed of drugs used to treat melanoma, a type of skin cancer. These drugs are typically used in combination with other treatments such as surgery, radiation, and immunotherapy. Commonly used drugs include targeted therapies, immunotherapies, and chemotherapy. Targeted therapies are designed to target specific molecules in the cancer cells, while immunotherapies are designed to boost the body's own immune system to fight the cancer. Chemotherapy is used to kill cancer cells.
The Melanoma Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Roche, Novartis, and Pfizer. Other companies include AstraZeneca, Eli Lilly, and GlaxoSmithKline. Show Less Read more